Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88129597 | FILING DATE | 09/24/2018 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | HARDY LUDLOW, TARAH KI |
L.O. ASSIGNED | 110 |
PUB INFORMATION |
|||
RUN DATE | 07/29/2020 | ||
PUB DATE | 12/04/2018 | ||
STATUS | 732-THIRD EXTENSION - GRANTED | ||
STATUS DATE | 07/27/2020 | ||
LITERAL MARK ELEMENT | RSM | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | RSM |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 20-OWNER AT PUBLICATION |
NAME | Finch Therapeutics, Inc. |
ADDRESS | 200 Inner Belt Road, Suite 400 Somerville, MA 02143 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PARENT OF |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
07/29/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 031 |
07/27/2020 | EX3G | S | EXTENSION 3 GRANTED | 030 |
07/27/2020 | EXT3 | S | EXTENSION 3 FILED | 029 |
07/27/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 028 |
01/17/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 027 |
01/15/2020 | EX2G | S | EXTENSION 2 GRANTED | 026 |
01/15/2020 | EXT2 | S | EXTENSION 2 FILED | 025 |
01/15/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 024 |
08/20/2019 | NOAC | E | CORRECTED NOA E-MAILED | 023 |
08/20/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 022 |
08/19/2019 | EX1G | S | EXTENSION 1 GRANTED | 021 |
07/25/2019 | EXT1 | S | EXTENSION 1 FILED | 020 |
08/19/2019 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | 019 |
07/25/2019 | DRRR | I | DIVISIONAL REQUEST RECEIVED | 018 |
08/07/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 017 |
07/25/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 016 |
07/25/2019 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | 015 |
01/29/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 014 |
12/04/2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 013 |
12/04/2018 | PUBO | A | PUBLISHED FOR OPPOSITION | 012 |
11/14/2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 011 |
11/01/2018 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | 010 |
10/27/2018 | ALIE | A | ASSIGNED TO LIE | 009 |
10/15/2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 008 |
10/15/2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 007 |
10/15/2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 006 |
10/15/2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | 005 |
10/15/2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 004 |
10/10/2018 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
09/29/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
09/27/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Rachelle A. Dubow, Esquire |
CORRESPONDENCE ADDRESS | Rachelle A. Dubow, Esquire MORGAN, LEWIS & BOCKIUS LLP Attn: TMSU 1 FEDERAL ST BOSTON MA 02110 |
DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Finch Therapeutics, Inc. |
ADDRESS | 200 Inner Belt Road, Suite 400 Somerville, MA 02143 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |